Dry Needling Dosage in the Treatment of Myofascial Neck Pain

• Sponsor: Universidad Rey Juan Carlos (Other)
• Overall Status: Completed
• CT.gov ID: NCT02190890
• Collaborator: (none)
• Enrollment: 94
• Arms: 4
• Duration (Months): 27

Study Details

Study Description

Brief Summary

The purpose of this study are (1) to determine the effectiveness of different dry needling dosages in the treatment of myofascial trigger points in the upper trapezius muscle in patients with myofascial neck pain, (2) to assess postneedling soreness and tenderness and (3) evaluate the influence of psychological factors on the perception of postneedling soreness.

Condition or Disease	Intervention/Treatment	Phase
Neck Pain	Procedure: Dry needling; Procedure: Control	N/A

Study Design

• Study Type: Interventional
• Actual Enrollment: 94 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: Double (Participant, Outcomes Assessor)
• Primary Purpose: Treatment
• Official Title: Effects of Different Deep Dry Needling Dosages on Pain and Postneedling Soreness in the Treatment of Patients With Cervical Myofascial Pain
• Study Start Date: Sep 1, 2013
• Actual Primary Completion Date: May 1, 2014
• Actual Study Completion Date: Dec 1, 2015

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Dry needling: 4 local twitch responses Deep dry needling in the active myofascial trigger point in the upper trapezius muscle. The muscle fibers were repeatedly perforated by rapidly inserting and partially withdrawing the needle from the MTrP until 4 local twitch responses were elicited.	Procedure: Dry needling
Experimental: Dry needling: 6 local twitch responses Deep dry needling in the active myofascial trigger point in the upper trapezius muscle. The muscle fibers were repeatedly perforated by rapidly inserting and partially withdrawing the needle from the MTrP until 6 local twitch responses were elicited.	Procedure: Dry needling
Experimental: Dry needling: Until no more local twitch responses elicited Deep dry needling in the active myofascial trigger point in the upper trapezius muscle. The muscle fibers were repeatedly perforated by rapidly inserting and partially withdrawing the needle from the MTrP until no more local twitch responses were elicited.	Procedure: Dry needling
Active Comparator: Control The needle was inserted 1.5 cm away from the trigger point in the trapezius muscle and withdrawn without any consecutive insertion.	Procedure: Control

Outcome Measures

Primary Outcome Measures

1. Pain [1 week]

   Visual analog scale. A 100mm VAS, ranging from 0mm (no pain) to 100mm (worst imaginable pain).

2. Postneedling soreness [1 week]

   Visual analog scale. A 100mm VAS, ranging from 0mm (no pain) to 100mm (worst imaginable pain).

Secondary Outcome Measures

1. Pressure pain threshold [1 week]

   Three consecutive trials of pressure pain threshold on the active trigger point at a rate of 1 kg/sec at intervals of 30 seconds were conducted.

2. Cervical range of motion [1 week]

   The subjects sat in a chair and a CROM goniometer was placed over the head. They were asked to perform active neck movements to the fullest extent of their mobility. Each movement was recorded three times and the average value was calculated.

3. Neck disability [1 week]

   Neck Disability Index questionnarie was completed.

4. Pain in cervical range of motion [1 week]

   Pain in a numerical pain rating scale during all cervical movements was recorded.

5. Psychological factors [Pre-intervention]

   State Trait Anxiety Inventory (STAI-T)

6. Psychological factors [Pre-intervention]

   Beck Depression Inventory (BDI-II)

7. Psychological factors [Pre-intervention]

   Tampa Scale for Kinesiophobia

8. Psychological factors [Pre-intervention]

   Pain Catastrophizing Scale

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 53 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Diagnosis of an active myofascial trigger point. Neck pain: Superior to 3 cm in VAS

Exclusion Criteria:

• Neck area: Fracture, radiculopathy, previous surgery, previous needling treatment in the last 6 months, previous analgesic medication (24 hours), psychiatric disease

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• Universidad Rey Juan Carlos

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Josue Fernandez Carnero, PhD, Universidad Rey Juan Carlos
• ClinicalTrials.gov Identifier: NCT02190890
• Other Study ID Numbers: 16/2013
• First Posted: Jul 15, 2014
• Last Update Posted: Dec 6, 2017
• Last Verified: Dec 1, 2017

• Additional relevant MeSH terms: Neck Pain

Study Results

No Results Posted as of Dec 6, 2017